Autism Screening in the First Year and Beyond: Comparison of Multiple Measures
Autism Research · 2026
DOI: 10.1002/aur.70340 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Autism Research, 2026. Verfasst von Devon N Gangi und 7 weiteren Autor:innen. Beteiligte Einrichtung: MIND Institute, Department of Psychiatry and Behavioral Sciences, University of California-Davis, Sacramento, California, USA. Hauptthemen laut MEDLINE: Mass Screening, Autistic Disorder, Autism Spectrum Disorder. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Autism screening aids in early detection and diagnosis. Several screeners are available for toddlers 16 months and older, but there is little data on the accuracy of screening measures used in the first year of life. A community sample ( N = 1641) completed three screeners—M‐CHAT‐R, ITC, VIRSA—online at 6, 9, 12, 18, and 24 months of age (including exploratory use of M‐CHAT‐R prior to 16 months). At 36 months, outcomes of ASD or Non‐ASD were determined by tele‐evaluation and outcome surveys. Psychometric properties were assessed for all screeners at all ages, both used individually and in combination. When used in the first year of life (6–12 months), psychometric properties were in the poor range, with area under the curve (AUC) < 0.70 for all three screeners, whether used in isolation or combination. At 18 and 24 months, the M‐CHAT‐R and ITC outperformed the VIRSA, with psychometric properties in the fair range (AUC 0.70–0.79) used in isolation and the good range (AUC ≥ 0.80) when used in combination. Using the M‐CHAT‐R and ITC at more than one age in the second year also fell in the good range. This study, using procedures to address limitations of prior screening studies and follow screen‐negative cases, found that none of the three screeners had adequate psychometric properties in the first year. At 18 and 24 months, findings supported the use of multiple screeners, either in combination or longitudinally, for best prediction of autism diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MIND Institute, Department of Psychiatry and Behavioral Sciences, University of California-Davis, Sacramento, California, USA.
- Rady Children's Health, Autism Discovery Institute, San Diego, California, USA.
- Information and Educational Technology, Enterprise Applications, University of California-Davis, Sacramento, California, USA.
ORCID-Profile: Devon N Gangi, Chandni Parikh, Monique Moore Hill, Gregory S Young, Sally Ozonoff
Förderung
- NIMH NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Gangi, D. N., Parikh, C., Hill, M. M., Maqbool, S., Ni, R., Dvorak, S., Young, G. S., & Ozonoff, S. (2026). Autism Screening in the First Year and Beyond: Comparison of Multiple Measures. Autism Research. https://doi.org/10.1002/aur.70340
Vancouver
Gangi DN, Parikh C, Hill MM, Maqbool S, Ni R, Dvorak S, et al. Autism Screening in the First Year and Beyond: Comparison of Multiple Measures. Autism Research. 2026. doi:10.1002/aur.70340
BibTeX
@article{Gangi2026,
author = {Gangi, Devon N and Parikh, Chandni and Hill, Monique Moore and Maqbool, Shyeena and Ni, Rachel and Dvorak, Simon and Young, Gregory S and Ozonoff, Sally},
title = {Autism Screening in the First Year and Beyond: Comparison of Multiple Measures},
journal = {Autism Research},
year = {2026},
doi = {10.1002/aur.70340}
}
EUVIMED